Cargando…
RGD-modified dihydrolipoamide dehydrogenase conjugated to titanium dioxide nanoparticles – switchable integrin-targeted photodynamic treatment of melanoma cells
The photocytotoxic effect of UVA-excited titanium dioxide (TiO(2)), which is caused by the generation of reactive oxygen species (ROS), is often used in medical applications, such as cancer treatment. Photodynamic-therapy (PDT) is applied in several cancer models including cutaneous melanoma (CM), h...
Autores principales: | Dayan, Avraham, Fleminger, Gideon, Ashur-Fabian, Osnat |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Royal Society of Chemistry
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9078614/ https://www.ncbi.nlm.nih.gov/pubmed/35541888 http://dx.doi.org/10.1039/c7ra13777j |
Ejemplares similares
-
Biochemical characterization of patients with dihydrolipoamide dehydrogenase deficiency
por: Wongkittichote, Parith, et al.
Publicado: (2023) -
The phenotypic spectrum of dihydrolipoamide dehydrogenase deficiency in Saudi Arabia
por: Alfarsi, Anar, et al.
Publicado: (2021) -
Toward the development of a novel non-RGD cyclic peptide drug conjugate for treatment of human metastatic melanoma
por: Redko, Boris, et al.
Publicado: (2016) -
Mitochondrial Dihydrolipoamide Dehydrogenase Is Upregulated in Response to Intermittent Hypoxic Preconditioning
por: Li, Rongrong, et al.
Publicado: (2015) -
Biochemical and structural characterization of the apicoplast dihydrolipoamide dehydrogenase of Plasmodium falciparum
por: Laine, Larissa M., et al.
Publicado: (2015)